ZNF439

gene
On this page

Also known as DKFZp571K0837

Summary

ZNF439 (zinc finger protein 439, HGNC:20873) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 439 (Q8NDP4). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 90594 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 76 total
  • MANE Select transcript: NM_001348719

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20873
Approved symbolZNF439
Namezinc finger protein 439
Location19p13.2
Locus typegene with protein product
StatusApproved
AliasesDKFZp571K0837
Ensembl geneENSG00000171291
Ensembl biotypeprotein_coding
Entrez90594

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000304030, ENST00000442091, ENST00000455282, ENST00000592495, ENST00000592534, ENST00000682736

RefSeq mRNA: 9 — MANE Select: NM_001348719 NM_001348718, NM_001348719, NM_001348720, NM_001348721, NM_001348722, NM_001348723, NM_001348724, NM_001348725, NM_152262

CCDS: CCDS12268, CCDS86705, CCDS92520

Canonical transcript exons

ENST00000682736 — 4 exons

ExonStartEnd
ENSE000035256111186653711866597
ENSE000039185981186620511866331
ENSE000039212191184872611848930
ENSE000039213521186730611869486

Expression profiles

Bgee: expression breadth ubiquitous, 199 present calls, max score 85.99.

FANTOM5 (CAGE): breadth broad, TPM avg 4.6393 / max 118.5534, expressed in 910 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1739694.6393910

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534385.99gold quality
ventricular zoneUBERON:000305385.64gold quality
ganglionic eminenceUBERON:000402385.37gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.44gold quality
cerebellar hemisphereUBERON:000224582.98gold quality
cerebellar cortexUBERON:000212982.90gold quality
calcaneal tendonUBERON:000370182.21gold quality
right hemisphere of cerebellumUBERON:001489082.13gold quality
cerebellumUBERON:000203781.68gold quality
adenohypophysisUBERON:000219680.50gold quality
left ovaryUBERON:000211979.67gold quality
metanephros cortexUBERON:001053379.62gold quality
granulocyteCL:000009479.44gold quality
right ovaryUBERON:000211879.44gold quality
spleenUBERON:000210679.31gold quality
pituitary glandUBERON:000000779.12gold quality
right lobe of thyroid glandUBERON:000111978.48gold quality
left lobe of thyroid glandUBERON:000112078.47gold quality
small intestine Peyer’s patchUBERON:000345478.34gold quality
tendonUBERON:000004378.03gold quality
tibial arteryUBERON:000761077.98gold quality
popliteal arteryUBERON:000225077.97gold quality
thyroid glandUBERON:000204677.72gold quality
mucosa of transverse colonUBERON:000499177.26gold quality
ovaryUBERON:000099277.25gold quality
right lungUBERON:000216777.25gold quality
right coronary arteryUBERON:000162577.20gold quality
adrenal tissueUBERON:001830377.18gold quality
skin of abdomenUBERON:000141677.13gold quality
tibial nerveUBERON:000132377.10gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusZfp78ENSMUSG00000055150
rattus_norvegicusENSRNOG00000083797
drosophila_melanogasterCG2712FBGN0024975
drosophila_melanogasterPhsFBGN0036522
drosophila_melanogasterCG3281FBGN0260741

Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)

Protein

Protein identifiers

Zinc finger protein 439Q8NDP4 (reviewed: Q8NDP4)

All UniProt accessions (4): A0A0C4DG37, A0A804HI69, C9JMA7, Q8NDP4

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (9): NP_001335647, NP_001335648, NP_001335649, NP_001335650, NP_001335651, NP_001335652, NP_001335653, NP_001335654, NP_689475 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (15 total): zinc finger region 11, sequence variant 2, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NDP4-F169.510.25

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 55 (showing top): PEREZ_TP63_TARGETS, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MARTENS_TRETINOIN_RESPONSE_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, FOXN3_TARGET_GENES, NFKBIA_TARGET_GENES, MIR6867_5P, MIR4262, MIR6809_3P, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
transcription cis-regulatory region binding1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

316 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF439OR6S1Q8NH40583
ZNF439CWF19L2Q2TBE0445
ZNF439NUDT22Q9BRQ3416
ZNF439DENND11A4D1U4400
ZNF439VSTM2BA6NLU5377
ZNF439FAM53AQ6NSI3374
ZNF439RPS7P23821357
ZNF439DUS3LQ96G46355
ZNF439CTDSPL2Q05D32349
ZNF439CCDC181Q5TID7348
ZNF439TMEM205Q6UW68348
ZNF439BEND4Q6ZU67323
ZNF439USP54Q70EL1308
ZNF439HTR3EA5X5Y0300
ZNF439COMMD5Q9GZQ3299

IntAct

91 interactions, top by confidence:

ABTypeScore
ZNF439MDFIpsi-mi:“MI:0915”(physical association)0.830
MDFIZNF439psi-mi:“MI:0915”(physical association)0.830
GMNNZNF439psi-mi:“MI:0915”(physical association)0.780
ZNF439GMNNpsi-mi:“MI:0915”(physical association)0.780
KRTAP5-9ZNF439psi-mi:“MI:0915”(physical association)0.720
ZNF439KRTAP10-8psi-mi:“MI:0915”(physical association)0.720
ZNF439KRT40psi-mi:“MI:0915”(physical association)0.720
KRTAP10-8ZNF439psi-mi:“MI:0915”(physical association)0.720
ZNF439KRTAP5-9psi-mi:“MI:0915”(physical association)0.720
KRT40ZNF439psi-mi:“MI:0915”(physical association)0.720
MTUS2ZNF439psi-mi:“MI:0915”(physical association)0.670
ZNF439MTUS2psi-mi:“MI:0915”(physical association)0.670
CCNDBP1ZNF439psi-mi:“MI:0915”(physical association)0.560
KRTAP10-5ZNF439psi-mi:“MI:0915”(physical association)0.560
ZNF439KRTAP10-7psi-mi:“MI:0915”(physical association)0.560

BioGRID (40): ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), ZNF439 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), ZNF439 (Two-hybrid)

ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58

Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 25 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization929.5×2e-10

Disease & clinical

Clinical variants and AI predictions

ClinVar

76 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance58
Likely benign14
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

105 predictions. Top by Δscore:

VariantEffectΔscore
19:11866329:TAGG:Tdonor_loss1.0000
19:11866331:GGTA:Gdonor_loss1.0000
19:11866332:GTA:Gdonor_loss1.0000
19:11867295:A:AGacceptor_gain1.0000
19:11867296:T:Gacceptor_gain1.0000
19:11867300:T:TAacceptor_gain1.0000
19:11867303:CA:Cacceptor_loss1.0000
19:11867304:A:AGacceptor_gain1.0000
19:11867304:AG:Aacceptor_gain1.0000
19:11867305:G:Aacceptor_loss1.0000
19:11867305:G:GTacceptor_gain1.0000
19:11867305:GG:Gacceptor_gain1.0000
19:11867305:GGA:Gacceptor_gain1.0000
19:11867305:GGAGT:Gacceptor_gain1.0000
19:11866292:G:Tdonor_gain0.9900
19:11866332:G:GGdonor_gain0.9900
19:11866333:T:Gdonor_loss0.9900
19:11866532:TTTA:Tacceptor_loss0.9900
19:11866533:TTAGG:Tacceptor_loss0.9900
19:11866534:TAG:Tacceptor_loss0.9900
19:11866535:A:AGacceptor_gain0.9900
19:11866535:AGG:Aacceptor_loss0.9900
19:11866536:G:GCacceptor_loss0.9900
19:11866536:G:GGacceptor_gain0.9900
19:11866593:TTCAG:Tdonor_loss0.9900
19:11866594:TCAG:Tdonor_loss0.9900
19:11866595:CAGG:Cdonor_loss0.9900
19:11866596:AGGTA:Adonor_loss0.9900
19:11866597:GGTAA:Gdonor_loss0.9900
19:11866598:GT:Gdonor_loss0.9900

AlphaMissense

3376 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:11868240:T:CF391L0.987
19:11868242:C:AF391L0.987
19:11868242:C:GF391L0.987
19:11868408:T:CF447L0.985
19:11868410:C:AF447L0.985
19:11868410:C:GF447L0.985
19:11868156:T:CF363L0.982
19:11868158:T:AF363L0.982
19:11868158:T:GF363L0.982
19:11868324:T:CF419L0.979
19:11868326:C:AF419L0.979
19:11868326:C:GF419L0.979
19:11867820:T:CF251L0.976
19:11867822:T:AF251L0.976
19:11867822:T:GF251L0.976
19:11868492:T:CF475L0.974
19:11868494:C:AF475L0.974
19:11868494:C:GF475L0.974
19:11867904:T:CF279L0.971
19:11867906:C:AF279L0.971
19:11867906:C:GF279L0.971
19:11868330:T:CS421P0.969
19:11868414:T:CS449P0.967
19:11868241:T:CF391S0.958
19:11866238:T:CF28L0.955
19:11866240:C:AF28L0.955
19:11866240:C:GF28L0.955
19:11868281:C:AH404Q0.955
19:11868281:C:GH404Q0.955
19:11867736:T:CF223L0.953

dbSNP variants (sampled 300 via entrez): RS1000075737 (19:11860587 A>C), RS1000086154 (19:11864541 C>G), RS1000186843 (19:11849077 G>T), RS1000554986 (19:11847607 G>A), RS1001017853 (19:11849776 T>A), RS1001069775 (19:11849509 C>G,T), RS1001291508 (19:11869624 CT>C,CTT,CTTTTT), RS1001297620 (19:11854721 G>A), RS1001629376 (19:11857664 G>T), RS1001731737 (19:11851920 T>A), RS1001805399 (19:11852143 G>A), RS1001903943 (19:11855976 C>T), RS1001922850 (19:11854114 C>T), RS1002010841 (19:11847350 C>T), RS1002065448 (19:11850664 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST011358_11Academic attainment (English)3.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0011015educational attainment

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, decreases expression, affects cotreatment3
trichostatin Aaffects cotreatment, decreases expression2
bisphenol Saffects cotreatment, decreases methylation, increases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
GSK-J4decreases expression1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression1
CGP 52608increases reaction, affects binding1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
belinostatincreases expression1
dorsomorphinaffects cotreatment, decreases expression1
licochalcone Bincreases expression1
Resveratrolaffects cotreatment, increases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Benzo(a)pyreneincreases methylation1
Dexamethasoneaffects cotreatment, increases expression1
Hydralazineincreases expression, affects cotreatment1
Indomethacinaffects cotreatment, increases expression1
Lipopolysaccharidesdecreases expression, affects response to substance, increases expression1
Plant Extractsincreases expression, affects cotreatment1
Quercetindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Cadmium Chloridedecreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.